OraSure Technologies Inc

OSUR

OraSure Technologies Inc is a biotechnology company specializing in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. It is known for its focus on infectious disease testing, including HIV, hepatitis, and COVID-19, as well as other health screening and diagnostic solutions. The company's products are used in both healthcare settings and for at-home testing.

$2.65 -0.08 (-2.76%)
🚫 OraSure Technologies Inc does not pay dividends

Company News

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
GlobeNewswire Inc. • Orasure Technologies, Inc. • January 15, 2026

OraSure Technologies confirmed that activist investor Altai Capital has nominated two candidates, including founder Rishi Bajaj, for election to the company's Board of Directors at the 2026 Annual Meeting. The Board previously interviewed Bajaj but appointed an alternative candidate instead. OraSure highlighted its recent board refreshment with s...

OraSure Submits CT/NG Molecular Self-Test and Colli-Peeâ„¢ Urine Collection Device for FDA Review
GlobeNewswire Inc. • Na • January 5, 2026

OraSure Technologies announced the submission of two FDA applications at the end of 2025: one for a rapid molecular self-test for Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) that delivers results in approximately 30 minutes, and another for its Colli-Pee at-home urine collection device for STI testing. The CT/NG test addresses a marke...

Global At-Home Testing Market to Reach USD 11,877.8 Million by 2035 with a CAGR of 4.8%, Driven by Rising Consumer Demand for Self-Diagnostic Tools | Future Market Insights, Inc.
GlobeNewswire Inc. • Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.) • January 17, 2025

The global at-home testing market is expected to grow from $7.8 billion in 2025 to $11.9 billion by 2035, driven by increasing consumer demand for self-diagnostic tools. Key factors include rising healthcare spending, growing awareness of preventive healthcare, and technological advancements in diagnostic tools.

OraSure Technologies Acquires Sherlock Biosciences
Benzinga • Globe Newswire • December 19, 2024

OraSure Technologies has acquired Sherlock Biosciences, a global health company that develops next-generation diagnostic tests. The acquisition expands OraSure's pipeline with Sherlock's molecular diagnostics platform, which can provide rapid and accurate results for sexually transmitted infections.

Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights Inc.
GlobeNewswire Inc. • Na • October 29, 2024

The microbiome diagnostics industry is projected to grow at a CAGR of 13.4% from 2024 to 2032, driven by the rising demand for personalized medicine. Advancements in sequencing technologies and collaborations between research organizations are expected to drive the market.

Related Companies